With a legacy of innovative cancer research, groundbreaking discoveries, and world-class patient care, we are transforming the way cancer is understood, prevented, detected, diagnosed, treated, and ...

Objectives Small cell lung cancer (SCLC) has the most aggressive clinical course of pulmonary tumor and is treated in a different way from non-SCLC. However, the clinical value of FDG-PET/CT is not ...